SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-19-018002
Filing Date
2019-09-13
Accepted
2019-09-13 16:58:48
Documents
6
Effectiveness Date
2019-09-13

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs82019_adialpharma.htm S-8 84608
2 AMENDMENT NO.1 TO THE ADIAL PHARMACEUTICALS, INC. 2017 EQUITY INCENTIVE STOCK PL fs82019ex4-2_adialpharma.htm EX-4.2 8088
3 OPINION OF GRACIN & MARLOW, LLP REGARDING LEGALITY OF SHARES fs82019ex5-1_adialpharma.htm EX-5.1 10093
4 CONSENT OF FRIEDMAN LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM fs82019ex23-1_adialpharma.htm EX-23.1 2959
5 GRAPHIC ex5-1_001.jpg GRAPHIC 16171
6 GRAPHIC ex23-1_001.jpg GRAPHIC 18184
  Complete submission text file 0001213900-19-018002.txt   154593
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-233760 | Film No.: 191093113
SIC: 2834 Pharmaceutical Preparations